---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-21-004812"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2021-11-19T23:59:59+00:00"
generated_at: "2026-06-28T06:30:07.828713+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Arcadia Biosciences Chief Growth Officer Chris Cuvelier to Depart Nov 30, 2021

## Summary
- Chris Cuvelier's employment as Chief Growth Officer will end effective November 30, 2021.
- The decision was reached on November 15, 2021, as reported by Arcadia Biosciences.
- The company filed an 8-K with the SEC on November 19, 2021, disclosing the officer departure.

## SEC filing metadata
- accession: 0000950170-21-004812
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2021-11-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017021004812/0000950170-21-004812-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017021004812/rkda-20211115.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-21-004812
- JSON: https://secwatch.observer/filing/0000950170-21-004812.json
- Plain text: https://secwatch.observer/filing/0000950170-21-004812.txt

## Key facts
- Executive change
  Chris Cuvelier departed as Chief Growth Officer at Arcadia Biosciences, Inc..
  - Action: will end
  - Role: Chief Growth Officer
  source text: On November 15, 2021, Arcadia Biosciences, Inc. (the “Company”) and Chris Cuvelier determined that Mr. Cuvelier's employment as the Company’s Chief Growth Officer will end effective as of November 30, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1469443/000095017021004812/0000950170-21-004812-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.